Aqueous humor levels of vascular endothelial growth factor before and after intravitreal bevacizumab in type 3 versus type 1 and 2 neovascularization. A prospective, case-control study

American Journal of Ophthalmology

Volumn 153, Issue 1, 2012, Pages

  Dell'Omo, Roberto ^a,b   Cassetta, Marilluccia ^b   Dell'Omo, Ermanno ^b   Di Salvatore, Angela ^b   Hughes, John M ^c   Aceto, Fabiana ^a   Porcellini, Antonio ^a   Costagliola, Ciro ^a,b  

^a UNIVERSITY OF MOLISE   (Italy)

^b Casa di Cura Villa Maria   (Italy)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; VASCULOTROPIN;

AQUEOUS HUMOR; ARTICLE; CASE CONTROL STUDY; CATARACT EXTRACTION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; NEOVASCULARIZATION (PATHOLOGY); OUTCOME ASSESSMENT; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 83555164941     PISSN: 00029394     EISSN: 18791891     Source Type: Journal    
DOI: 10.1016/j.ajo.2011.06.001     Document Type: Article

References (45)

1. L.A. Yannuzzi, S. Negrao, T. Iida Retinal angiomatous proliferation in age-related macular degeneration Retina 21 5 2001 416 434
2. J.D.M. Gass, A. Agarwal, A.M. Lavina, K.A. Tawansky Focal inner retinal hemorrhages in patients with drusen: an early sign of occult choroidal anastomosis Retina 23 6 2003 741 751
3. R.A. Costa, D. Calucci, L. Paccola Occult chorioretinal anastomosis in age-related macular degeneration: a prospective study by optical coherence tomography Am J Ophthalmol 140 1 2005 107 116
4. K.B. Freund, I. Ho, I. Barbazetto Type 3 neovascularization: the expanded spectrum of retinal angiomatous proliferation Retina 28 2 2008 201 211
5. L.A. Yannuzzi, K.B. Freund, B.S. Takahashi Review of retinal angiomatous proliferation or type 3 neovascularization Retina 28 3 2008 375 384
6. K.B. Freund, S.A. Zweifel, M. Engelbert Do we need a new classification for choroidal neovascularization in age-related macular degeneration? Retina 30 9 2010 1333 1349
7. F. Viola, A. Massacesi, N. Orzalesi, R. Ratiglia, G. Staurenghi Retinal angiomatous proliferation Natural history and progression of visual loss Retina 29 6 2009 732 739
8. F. Bottoni, A. Massacesi, M. Cigada, F. Viola, I. Musico, G. Staurenghi Treatment of retinal angiomatous proliferation in age-related macular degeneration A series of 104 cases of retinal angiomatous proliferation Arch Ophthalmol 123 12 2005 1644 1650
9. S. Joeres, F.M.A. Heussen, T. Treziak, S. Bopp, A.M. Joussen Bevacizumab (Avastin) treatment in patients with retinal angiomatous proliferation Graefes Arch Clin Exp Ophthalmol 245 11 2007 1597 1602
10. C.B. Meyerle, K.B. Freund, D. Iturralde Intravitreal bevacizumab (Avastin) for retinal angiomatous proliferation Retina 27 4 2007 451 457
11. N.G. Ghazi, R.M. Knape, T.Q. Kirk, S.J. Tiedeman, B.P. Conway Intravitreal bevacizumab (Avastin) treatment of retinal angiomatous proliferation Retina 28 5 2008 689 695
12. M. Gharbiya, F. Allievi, V. Recupero, D. Martini, L. Mazzeo, C.B. Gabrieli Intravitreal bevacizumab as primary treatment for retinal angiomatous proliferation Twelve months results Retina 29 6 2009 740 749
13. L. Konstatinidis, E. Mameletzi, I. Mantel, J.A. Pournaras, L. Zografos, A. Ambresin Intravitreal ranibizumab (Lucentis) in the treatment of retinal angiomatous proliferation (RAP) Graefes Arch Clin Exp Ophthalmol 247 9 2009 1165 1171
14. T.S. Hemeida, P.A. Keane, L. Dustin, S.R. Sadda, A.A. Fawzi Long-term visual and anatomical outcomes following anti-VEGF monotherapy for retinal angiomatous proliferation Br J Ophthalmol 94 6 2010 701 705
15. M. Engelbert, S.A. Zweifel, K.B. Freund "Treat and extend" dosing of intravitreal antivascular endothelial growth factor therapy for type 3 neovascularization/retinal angiomatous proliferation Retina 29 10 2009 1424 1431
16. V.M. Reddy, R.L. Zamore, H.J. Kaplan Distribution of growth factors in subfoveal fibrovascular membranes in age-related macular degeneration and presumed ocular histoplasmosis syndrome Am J Ophthalmol 120 3 1995 291 301
17. A. Kvanta, P.V. Algvere, L. Berglin, S. Seregard Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor Invest Ophthalmol Vis Sci 37 9 1996 1929 1934
18. P.F. Lopez, B.D. Sippy, H.M. Lamber, A.B. Thach, D.R. Hinton Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age related macular degeneration-related choroidal neovascular membranes Invest Ophthalmol Vis Sci 37 5 1996 855 868
19. X. Yi, N. Ogata, M. Komada Vascular endothelial growth factor expression in choroidal neovascularization in rats Graefes Arch Clin Exp Ophthalmol 235 5 1997 313 319
20. M. Wada, N. Ogata, T. Otsuji, M. Uyama Expression of vascular endothelial growth factor and its receptor (KDR/flk-1) mRNA in experimental choroidal neovascularization Curr Eye Res 18 3 1999 203 213
21. L.P. Aiello, R.L. Avery, P.G. Arrigg Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders N Engl J Med 331 22 1994 1480 1487
22. A.P. Adamis, J.W. Miller, M.T. Bernal Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy Am J Ophthalmol 118 4 1994 445 450
23. J.A. Wells, R. Murthy, R. Chibber Levels of vascular endothelial growth factor are elevated in the vitreous of patients with subretinal neovascularisation Br J Ophthalmol 80 4 1996 363 366
24. H. Funatsu, H. Yamashita, H. Noma Aqueous humor levels of cytokines are related to vitreous levels and progression of diabetic retinopathy in diabetic patients Graefes Arch Clin Exp Ophthalmol 243 1 2005 3 8
25. H. Noma, H. Funatsu, M. Yamasaki Aqueous humour levels of cytokines are correlated to vitreous levels and severity of macular oedema in branch retinal vein occlusion Eye 22 1 2008 42 48
26. J. Pe'er, A. Shweiki, A. Itin, I. Hemo, H. Gnessin, E. Keshet Hypoxia induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular disease Lab Invest 72 6 1995 638 645
27. L.P. Aiello, J.M. Northrup, B.A. Keyt, H. Takagi, M.A. Iwamoto Hypoxic regulation of vascular endothelial growth factor in retinal cells Arch Ophthalmol 113 12 1995 1538 1544
28. J. Stone, A. Itin, J. Alon Development of retinal vasculature is mediated by hypoxia induced vascular endothelial growth factor expression by neuroglia J Neurosci 15 7 1995 4738 4747
29. D.M. Monson, J.R. Smith, M.L. Klein, D.J. Wilson Clinicopathologic correlation of retinal angiomatous proliferation Arch Ophthalmol 126 12 2008 1664 1668
30. P.A. Campochiaro, D.F. Choy, D.V. Do Monitoring ocular drug therapy by analysis of aqueous samples Ophthalmology 116 11 2009 2158 2164
31. M.I. Roh, H.S. Kim, J.H. Song, J.B. Lim, H.J. Koh, O.W. Kwon Concentration of cytokines in the aqueous humor of patients with nave, recurrent and regressed CNV associated with AMD after bevacizumab treatment Retina 29 4 2009 523 529
32. W.M. Chan, T.Y.Y. Lai, K.P. Chan Changes in aqueous vascular endothelial growth factor and pigment epitelial-derived factor levels following intravitreal bevacizumab injections for choroidal neovascularization secondary to age-related macular degeneration or pathologic myopia Retina 28 9 2008 1308 1313
33. J.K. Ahn, H.J. Moon Changes in aqueous vascular endothelial growth factor and pigment epithelium-derived factor after ranibizumab alone or combined with verteporfin for exudative age-related macular degeneration Am J Ophthalmol 148 5 2009 718 724
34. T.Y. Lai, D.T. Liu, K.P. Chan, F.O. Luk, C.P. Pang, D.S. Lam Visual outcomes and growth factor changes of two dosages of intravitreal bevacizumab for neovascular age-related macular degeneration: a randomized, controlled trial Retina 29 9 2009 1218 1226
35. M. Funk, M. Georgopoulos, T. Benesch Neovascular age-related macular degeneration: intraocular cytokines and growth factors and the influence of therapy with ranibizumab Ophthalmology 116 12 2009 2393 2399
36. N. Ogata, M. Nishikawa, T. Nishimura, Y. Mitsuma, M. Matsumura Unbalanced vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in diabetic retinopathy Am J Ophthalmol 134 3 2002 348 353
37. G. Gao, Y. Li, D. Zhang, S. Gee, C. Crosson, J. Ma Unbalanced expression of VEGF and PEDF in ischemia-induced retinal neovascularization FEBS Lett 489 2-3 2001 270 276
38. U. Schmidt-Erfurth, U. Schlötzer-Schrehard, C. Cursiefen, S. Michels, A. Beckendorf, G.O. Naumann Influence of photodynamic therapy on expression of vascular endothelial growth factor (VEGF), VEGF receptor 3, and pigment epithelium-derived factor Invest Ophthalmol Vis Sci 44 10 2003 4473 4480
39. O. Tatar, A. Adam, K. Shinoda Expression of VEGF and PEDF in choroidal neovascular membranes following verteporfin photodynamic therapy Am J Ophthalmol 142 1 2006 95 104
40. O. Tatar, K. Shinoda, A. Adam Effect of verteporfin photodynamic therapy on endostatin and angiogenesis in human choroidal neovascular membranes Br J Ophthalmol 91 2 2007 166 173
41. I. Krebs, S. Binder, U. Stolba A new treatment regimen in combined intravitreal injection of triamcinolone acetonide and photodynamic therapy Graefes Arch Clin Exp Ophthalmol 244 7 2006 863 867
42. K.B. Freund, C.M. Klais, C.M. Eandi Sequenced combined intravitreal triamcinolone and indocyanine green angiography-guided photodynamic therapy for retinal angiomatous proliferation Arch Ophthalmol 124 4 2006 487 492
43. H. Koizumi, T. Iida, M. Saito, D. Nagayama, I. Maruko Choroidal circulatory disturbances associated with retinal angiomatous proliferation on indocyanine green angiography Graefes Arch Clin Exp Ophthalmol 246 4 2008 515 520
44. McBain VA, Kumari R, Townend J, Lois N. Geographic atrophy in retinal angiomatous proliferation. Retina. Forthcoming.
45. H.E. Grossniklaus, W.R. Green Choroidal neovascularization Am J Ophthalmol 137 3 2004 496 503